1. Home
  2. ICD-10-PCS MS-DRG V42.0
  3. Procedure Codes in MS-DRG 319 - Other Endovascular Cardiac Valve Procedures With MCC

Procedure Codes in MS-DRG 319 - Other Endovascular Cardiac Valve Procedures With MCC

The Medicare Severity Diagnosis-Related Group (MS-DRG) is a patient classification system used to categorize hospital cases based on clinical similarity and expected resource use. MS-DRGs organize all possible principal diagnoses into mutually exclusive groups known as Major Diagnostic Categories (MDCs), which help determine reimbursement under the Medicare Inpatient Prospective Payment System.

This section lists the procedure codes included in MS-DRG V42.0: Other Endovascular Cardiac Valve Procedures with MCC from October 1, 2024, through September 30, 2025.

MS-DRG: 319

MS-DRG Title: Other Endovascular Cardiac Valve Procedures with MCC

MCD: 05

Relative Weight: Relative Weight
The relative weight of a diagnostic related group determines the reimbursement rate based on the severity of a patient's illness and the associated cost of care during hospitalization.

Geometric LOS: Geometric Length of Stay
The geometric mean length of stay (GMLOS) is used by Medicare to calculate the reimbursement for patients whose medical treatment takes a much longer or shorter time than average.

Arithmetic LOS: Arithmetic Length of Stay
The average length of stay (ALOS) reflects the average number of days a patient spends in a hospital for each admission.

  • 025 - Heart and Great Vessels, Destruction

    • 025F3ZZ - Destruction of Aortic Valve, Percutaneous Approach

    • 025G3ZZ - Destruction of Mitral Valve, Percutaneous Approach

    • 025H3ZZ - Destruction of Pulmonary Valve, Percutaneous Approach

    • 025J3ZZ - Destruction of Tricuspid Valve, Percutaneous Approach

  • 027 - Heart and Great Vessels, Dilation

    • 027F34Z - Dilation of Aortic Valve with Drug-eluting Intraluminal Device, Percutaneous Approach

    • 027F3DZ - Dilation of Aortic Valve with Intraluminal Device, Percutaneous Approach

    • 027F3ZZ - Dilation of Aortic Valve, Percutaneous Approach

    • 027G34Z - Dilation of Mitral Valve with Drug-eluting Intraluminal Device, Percutaneous Approach

    • 027G3DZ - Dilation of Mitral Valve with Intraluminal Device, Percutaneous Approach

    • 027G3ZZ - Dilation of Mitral Valve, Percutaneous Approach

    • 027H34Z - Dilation of Pulmonary Valve with Drug-eluting Intraluminal Device, Percutaneous Approach

    • 027H3DZ - Dilation of Pulmonary Valve with Intraluminal Device, Percutaneous Approach

    • 027H3ZZ - Dilation of Pulmonary Valve, Percutaneous Approach

    • 027J34Z - Dilation of Tricuspid Valve with Drug-eluting Intraluminal Device, Percutaneous Approach

    • 027J3DZ - Dilation of Tricuspid Valve with Intraluminal Device, Percutaneous Approach

    • 027J3ZZ - Dilation of Tricuspid Valve, Percutaneous Approach

  • 02B - Heart and Great Vessels, Excision

    • 02BF3ZZ - Excision of Aortic Valve, Percutaneous Approach

    • 02BG3ZZ - Excision of Mitral Valve, Percutaneous Approach

    • 02BH3ZZ - Excision of Pulmonary Valve, Percutaneous Approach

    • 02BJ3ZZ - Excision of Tricuspid Valve, Percutaneous Approach

  • 02Q - Heart and Great Vessels, Repair

    • 02QF3ZJ - Repair Aortic Valve created from Truncal Valve, Percutaneous Approach

    • 02QF3ZZ - Repair Aortic Valve, Percutaneous Approach

    • 02QG3ZE - Repair Mitral Valve created from Left Atrioventricular Valve, Percutaneous Approach

    • 02QG3ZZ - Repair Mitral Valve, Percutaneous Approach

    • 02QH3ZZ - Repair Pulmonary Valve, Percutaneous Approach

    • 02QJ3ZG - Repair Tricuspid Valve created from Right Atrioventricular Valve, Percutaneous Approach

    • 02QJ3ZZ - Repair Tricuspid Valve, Percutaneous Approach

  • 02T - Heart and Great Vessels, Resection

    • 02TH3ZZ - Resection of Pulmonary Valve, Percutaneous Approach

  • 02V - Heart and Great Vessels, Restriction

    • 02VG3ZZ - Restriction of Mitral Valve, Percutaneous Approach

  • 02W - Heart and Great Vessels, Revision

    • 02WF38Z - Revision of Zooplastic Tissue in Aortic Valve, Percutaneous Approach

    • 02WF3JZ - Revision of Synthetic Substitute in Aortic Valve, Percutaneous Approach

    • 02WF3KZ - Revision of Nonautologous Tissue Substitute in Aortic Valve, Percutaneous Approach

    • 02WG37Z - Revision of Autologous Tissue Substitute in Mitral Valve, Percutaneous Approach

    • 02WG38Z - Revision of Zooplastic Tissue in Mitral Valve, Percutaneous Approach

    • 02WG3JZ - Revision of Synthetic Substitute in Mitral Valve, Percutaneous Approach

    • 02WG3KZ - Revision of Nonautologous Tissue Substitute in Mitral Valve, Percutaneous Approach

    • 02WH37Z - Revision of Autologous Tissue Substitute in Pulmonary Valve, Percutaneous Approach

    • 02WH38Z - Revision of Zooplastic Tissue in Pulmonary Valve, Percutaneous Approach

    • 02WH3JZ - Revision of Synthetic Substitute in Pulmonary Valve, Percutaneous Approach

    • 02WH3KZ - Revision of Nonautologous Tissue Substitute in Pulmonary Valve, Percutaneous Approach

    • 02WJ37Z - Revision of Autologous Tissue Substitute in Tricuspid Valve, Percutaneous Approach

    • 02WJ38Z - Revision of Zooplastic Tissue in Tricuspid Valve, Percutaneous Approach

    • 02WJ3JZ - Revision of Synthetic Substitute in Tricuspid Valve, Percutaneous Approach

    • 02WJ3KZ - Revision of Nonautologous Tissue Substitute in Tricuspid Valve, Percutaneous Approach

  • X28 - New Technology, Cardiovascular System, Division

    • X28F3VA - Division of Aortic Valve using Intraluminal Bioprosthetic Valve Leaflet Splitting Technology in Existing Valve, Percutaneous Approach, New Technology Group 10